VAERS 1079956
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6240
- Staat
- MA
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 16.10.2021
- Impfdatum
- 28.02.2021
- Beginn
- 28.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / RA
Symptomtext
Back muscle pain from neck to waist; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6230) via an unspecified route of administration in the right arm on 28Feb2021 at 09:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and the patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), bupropion hydrochloride (BUPROPION HCL XL), both were for an unknown indication, from an unknown date and unknown if ongoing. On 28Feb2021 at 10:30, 1 hour after vaccination the patient experienced back muscle pain from neck to waist and 8 days lasted with the pain staying the same. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event back muscle pain from neck to waist was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Hypertension
- Andere Medikamente
- LISINOPRIL; BUPROPION HCL XL
- Allergien
- -
- Vorherige Impfungen
- -